Metra, M
Eichhoff OM, Stoffel CI, Kasler J, Briker L, Turko P, Karsai G, et al
Could Mounjaro be the better option for managing type 2 diabetes and weight loss Compared to other GLP-1s, how does Mounjaro compare for people with type 2 diabetes
States reported new or expanded children/youth mental health initiatives in the following areas: Workforce
Temporary dose reduction during illness or significant life stress is reasonable, with resumption of escalation once circumstances normalize
For example, if you started a GLP-1 in September 2024 with a BMI of 37, but in July 2026 you've lost weight and now have a BMI of 34, the prescriber should attest in the prior authorization request that you met the BMI criteria of 35 or over when the GLP-1 therapy started